Forbion

Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients

Develops inobrodib, a first-in-class oral p300/CBP inhibitor for relapsed or refractory multiple myeloma

Advancing next-generation therapeutics for migraine and other headache disorders

Develops treatments for chronic lung diseases, focusing on viral respiratory infections

Develops preventive RNAi medicines for cardiovascular disease prediction and prevention